Celltrion announces Korean approval of biosimilar monoclonal antibody24 Jul 2012Scott BeeserOn July 23, 2012, Celltrion announced the approval by the Korean Food and Drug Administration of REMSIMA, its biosimilar anti-TNFα monoclonal antibody....Read More